CD4 and neoplasm: Mechanistically, ITK is required for TCR signaling and CXCR4 signaling, and thus critical for malignant T cell proliferation, differentiation and migration, while preventing anti-tumor immune responses by inhibiting TH1 CD4 T cell differentiation (49, 50, 66).